3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
10
Neoplasms
4
Neoplasm Metastasis
3
Triple Negative Breast Neoplasms
2
Squamous Cell Carcinoma of Head and Neck
2
Recurrence
2
Head and Neck Neoplasms
2
Endometrial Neoplasms
2
Uterine Cervical Neoplasms
1
Unilateral Breast Neoplasms
1
Spinal Cord Neoplasms
1
Small Cell Lung Carcinoma
1
Sarcoma, Kaposi
1
Sarcoma
1
Recurrent Ovarian High Grade Serous Adenocarcinoma
1
Pathologic Complete Response
1
Ovarian Neoplasms
1
Neoplasms, Squamous Cell
1
Neoplasms by Site
1
Multiple Myeloma
1
Meningioma
1
Lymphoma, Non-Hodgkin
1
Low Grade Serous Ovarian Carcinoma
1
Locally Advanced (Inoperable) or Metastatic Breast Cancer
1
Liposarcoma
1
Leiomyosarcoma
1
Hereditary Sensory and Autonomic Neuropathies
1
Hemangiosarcoma
1
HR+/HER2- Breast Cancer
1
Glioma
1
Interventions
X-Rays
6
Specimen Handling
6
Cyclophosphamide
6
Phantoms, Imaging
5
Magnetic Resonance Spectroscopy
4
fludarabine
3
Nuclear Medicine Department, Hospital
3
Doxorubicin
3
Biopsy
3
ulixertinib
2
tipifarnib
2
selpercatinib
2
mifamurtide
2
ivosidenib
2
fludarabine phosphate
2
ensartinib
2
cabozantinib
2
Methotrexate
2
Mesna
2
Ifosfamide
2
Gemcitabine
2
Cisplatin
2
trastuzumab deruxtecan
1
tazemetostat
1
talazoparib
1
selinexor
1
pembrolizumab
1
pazopanib
1
palbociclib
1
olaparib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Osteosarcoma
×
abemaciclib
×
30 days
×
Clear all
No trials found.